+

WO2002061079A3 - Biligands - Google Patents

Biligands Download PDF

Info

Publication number
WO2002061079A3
WO2002061079A3 PCT/GB2002/000364 GB0200364W WO02061079A3 WO 2002061079 A3 WO2002061079 A3 WO 2002061079A3 GB 0200364 W GB0200364 W GB 0200364W WO 02061079 A3 WO02061079 A3 WO 02061079A3
Authority
WO
WIPO (PCT)
Prior art keywords
biligands
aptamers
diagnostic assays
assays
diagnostic
Prior art date
Application number
PCT/GB2002/000364
Other languages
English (en)
Other versions
WO2002061079A2 (fr
Inventor
Abdessamad Tahiri-Alaoui
William S James
Original Assignee
Isis Innovation
Abdessamad Tahiri-Alaoui
William S James
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0102271A external-priority patent/GB0102271D0/en
Priority claimed from GB0102273A external-priority patent/GB0102273D0/en
Priority claimed from GB0102270A external-priority patent/GB0102270D0/en
Priority claimed from GB0102272A external-priority patent/GB0102272D0/en
Application filed by Isis Innovation, Abdessamad Tahiri-Alaoui, William S James filed Critical Isis Innovation
Priority to AU2002226571A priority Critical patent/AU2002226571A1/en
Publication of WO2002061079A2 publication Critical patent/WO2002061079A2/fr
Publication of WO2002061079A3 publication Critical patent/WO2002061079A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/322—2'-R Modification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne des biligands comprenant au moins deux aptamères, utilisés dans des analyses diagnostiques.
PCT/GB2002/000364 2001-01-29 2002-01-29 Biligands WO2002061079A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002226571A AU2002226571A1 (en) 2001-01-29 2002-01-29 Biligands

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB0102271A GB0102271D0 (en) 2001-01-29 2001-01-29 Streptavidin
GB0102270.6 2001-01-29
GB0102273A GB0102273D0 (en) 2001-01-29 2001-01-29 Hiv-1
GB0102273.0 2001-01-29
GB0102270A GB0102270D0 (en) 2001-01-29 2001-01-29 Immobilisation
GB0102272.2 2001-01-29
GB0102272A GB0102272D0 (en) 2001-01-29 2001-01-29 Biligands
GB0102271.4 2001-01-29

Publications (2)

Publication Number Publication Date
WO2002061079A2 WO2002061079A2 (fr) 2002-08-08
WO2002061079A3 true WO2002061079A3 (fr) 2003-09-04

Family

ID=27447919

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/GB2002/000391 WO2002061125A2 (fr) 2001-01-29 2002-01-29 Immobilisation
PCT/GB2002/000364 WO2002061079A2 (fr) 2001-01-29 2002-01-29 Biligands

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/GB2002/000391 WO2002061125A2 (fr) 2001-01-29 2002-01-29 Immobilisation

Country Status (2)

Country Link
AU (2) AU2002226584A1 (fr)
WO (2) WO2002061125A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2407825A1 (fr) * 2002-10-11 2004-04-11 Andrew J. Simmonds Marquage par la methode trap : nouvelle methode d'identification et de purification de complexes arn-proteine
DE102004053918B4 (de) * 2004-11-05 2007-06-14 Analyticon Biotechnologies Ag Aptamerbasiertes Testsystem
AU2011341017A1 (en) * 2010-12-10 2013-07-25 Merck Patent Gmbh Bispecific aptamers mediating tumour cell lysis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996004403A1 (fr) * 1994-08-02 1996-02-15 Nexstar Pharmaceuticals, Inc. Molecules chimeriques selectionnees par procede selex (evolution systematique de ligands par enrichissement exponentiel)
WO1999027133A1 (fr) * 1997-11-26 1999-06-03 Medical Research Council Procedure selex amelioree et aptamere anti-cd4
WO1999060169A1 (fr) * 1998-05-20 1999-11-25 Molecular Machines, Inc. Dispositifs multimoleculaires, systemes d'administration de medicaments et selection de molecule unique
WO2001088123A1 (fr) * 2000-05-18 2001-11-22 Isis Innovation Limited Ligands specifiques a un isoforme de proteine prion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1183521B1 (fr) * 1999-05-14 2014-03-19 Brandeis University Detection au moyen d'aptamère

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996004403A1 (fr) * 1994-08-02 1996-02-15 Nexstar Pharmaceuticals, Inc. Molecules chimeriques selectionnees par procede selex (evolution systematique de ligands par enrichissement exponentiel)
WO1999027133A1 (fr) * 1997-11-26 1999-06-03 Medical Research Council Procedure selex amelioree et aptamere anti-cd4
WO1999060169A1 (fr) * 1998-05-20 1999-11-25 Molecular Machines, Inc. Dispositifs multimoleculaires, systemes d'administration de medicaments et selection de molecule unique
WO2001088123A1 (fr) * 2000-05-18 2001-11-22 Isis Innovation Limited Ligands specifiques a un isoforme de proteine prion

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BACHLER MONIKA ET AL: "StreptoTag: A novel method for the isolation of RNA-binding proteins.", RNA (NEW YORK), vol. 5, no. 11, November 1999 (1999-11-01), pages 1509 - 1516, XP002237133, ISSN: 1355-8382 *
DAVIS ET AL: "STAINING OF CELL SURFACE HUMAN CD4 WITH 2'-F-PYRIMIDINE-CONTAINING RNA APTAMERS FOR FLOW CYTOMETRY", NUCLEIC ACIDS RESEARCH, vol. 26, no. 17, 1 September 1998 (1998-09-01), pages 3915 - 3924, XP002095387, ISSN: 0305-1048 *
LIN Y ET AL: "INHIBITION OF MULTIPLE THERMOSTABLE DNA POLYMERASES BY A HETERODIMERIC APTAMER", JOURNAL OF MOLECULAR BIOLOGY, vol. 271, no. 1, 1997, pages 100 - 111, XP002927383, ISSN: 0022-2836 *
MALMGREN CHARLOTTA ET AL: "Antisense RNA control of plasmid R1 replication. The dominant product of the antisense RNA-mRNA binding is not a full RNA duplex.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, no. 19, 1997, pages 12508 - 12512, XP002237132, ISSN: 0021-9258 *
RINGQUIST S ET AL: "ANTI-L-SELECTIN OLIGONUCLEOTIDE LIGANDS RECOGNIZE CD62L-POSITIVE LEUKOCYTES: BINDING AFFINITY AND SPECIFICITY OF UNIVALENT AND BIVALENT LIGANDS", CYTOMETRY, vol. 33, 1998, pages 394 - 405, XP002927384, ISSN: 0196-4763 *
SRISAWAT C ET AL: "STREPTAVIDIN APTAMERS: AFFINITY TAGS FOR THE STUDY OF RNAS AND RIBONUCLEOPROTEINS", RNA, vol. 7, no. 4, April 2001 (2001-04-01), pages 632 - 641, XP001120463, ISSN: 1355-8382 *
TAHIRI-ALAOUI ABDESSAMAD ET AL: "High affinity nucleic acid aptamers for streptavidin incorporated into bi-specific capture ligands.", NUCLEIC ACIDS RESEARCH, vol. 30, no. 10, 15 May 2002 (2002-05-15), pages e45, XP002237134, ISSN: 1362-4962 *

Also Published As

Publication number Publication date
WO2002061125A3 (fr) 2003-07-10
AU2002226571A1 (en) 2002-08-12
WO2002061079A2 (fr) 2002-08-08
AU2002226584A1 (en) 2002-08-12
WO2002061125A2 (fr) 2002-08-08

Similar Documents

Publication Publication Date Title
AUPR005600A0 (en) Diagnostic assay
AU2002256895A1 (en) Anti-TRAIL-R antibodies
AUPR604101A0 (en) Aptamers
AU2002344799A1 (en) Improved scale conditioning agents
AU2002365649A1 (en) Anti-dota antibody
AUPR969501A0 (en) Forfaiting transactions
AU2002318161A1 (en) Dye-labeled ribonucleotide triphosphates
MXPA03010307A (es) Panel de instrumentos/ensamble de partes.
AU2002359392A1 (en) Rapid prion-detection assay
AU2002353861A1 (en) Assay
AU2001280590A1 (en) 5-substituted 2-aryl-4-pyrimidinones
AU2002357178A1 (en) Diagnostic assays for bcwa
ITRM20020090A1 (it) Complesso di trasmissione differenziale.
DE50200825D1 (de) Fahrzeuggetriebe
WO2002061079A3 (fr) Biligands
AU2002362157A1 (en) Indicator
GB0101313D0 (en) Assay
ZA200200442B (en) Test mill.
GB0101312D0 (en) Assay
GB0100782D0 (en) Assay
AUPR921901A0 (en) Determining antibody specificity
AU2002247064A1 (en) Navigation aid
AUPR333401A0 (en) The C.R.B.R.W.S.S
GB0100290D0 (en) Assay
AU2002231998A1 (en) Background to the invention

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载